(Q73307385)
Statements
Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study (English)
A Belhabri
X Thomas
J Troncy
D Assouline
M Michallet
E Wattel
J D Tigaud
M Blanc
D Fière